ABVC BioPharma, Inc. (ABVC) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Win.
31/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinABVC / S&P 62.89% / 15.20% |
LoseABVC / S&P ABVC unavailable / 15.00% |
LoseABVC / S&P 11.11% / 50.40% |
| 2026-Q11/3 |
LoseABVC / S&P -54.46% / -4.33% |
LoseABVC / S&P ABVC unavailable / 11.30% |
WinABVC / S&P 81.82% / 27.70% |
| 2025-Q40/3 |
LoseABVC / S&P -29.93% / 2.65% |
LoseABVC / S&P ABVC unavailable / 9.00% |
LoseABVC / S&P -11.11% / 13.40% |
| 2025-Q32/3 |
WinABVC / S&P 36.63% / 8.12% |
LoseABVC / S&P ABVC unavailable / 4.61% |
WinABVC / S&P 141.67% / 13.45% |
| 2025-Q21/3 |
WinABVC / S&P 109.91% / 10.94% |
LoseABVC / S&P ABVC unavailable / 4.83% |
LoseABVC / S&P -70.33% / 10.63% |
| 2025-Q11/3 |
WinABVC / S&P 79.66% / -4.27% |
LoseABVC / S&P ABVC unavailable / 4.98% |
LoseABVC / S&P -85.43% / 10.57% |
| 2024-Q40/3 |
LoseABVC / S&P -13.62% / 2.41% |
LoseABVC / S&P -100.00% / 5.25% |
LoseABVC / S&P -74.58% / 6.15% |
| 2024-Q30/3 |
LoseABVC / S&P -11.76% / 5.89% |
LoseABVC / S&P -31.04% / 5.89% |
LoseABVC / S&P -96.60% / 6.11% |
| 2024-Q20/3 |
LoseABVC / S&P -40.92% / 4.28% |
LoseABVC / S&P -82.19% / 5.38% |
LoseABVC / S&P -76.36% / 5.12% |
| 2024-Q11/3 |
WinABVC / S&P 12.93% / 10.56% |
LoseABVC / S&P -97.63% / 5.71% |
LoseABVC / S&P -59.84% / 5.59% |
| 2023-Q40/3 |
LoseABVC / S&P 11.54% / 11.69% |
LoseABVC / S&P -84.28% / 6.81% |
LoseABVC / S&P -48.09% / 7.78% |
| 2023-Q32/3 |
LoseABVC / S&P -80.00% / -3.27% |
WinABVC / S&P 115.53% / 7.52% |
WinABVC / S&P 57.59% / -5.03% |
| 2023-Q22/3 |
LoseABVC / S&P -18.75% / 8.74% |
WinABVC / S&P 91.54% / 9.50% |
WinABVC / S&P 229.06% / -8.57% |
| 2023-Q12/3 |
LoseABVC / S&P 2.40% / 7.50% |
WinABVC / S&P 806.45% / 10.77% |
WinABVC / S&P 469.70% / -15.69% |
| 2022-Q42/3 |
LoseABVC / S&P -28.98% / 7.56% |
WinABVC / S&P 172.57% / 11.88% |
WinABVC / S&P 568.63% / -17.99% |
| 2022-Q31/3 |
LoseABVC / S&P -16.98% / -4.88% |
LoseABVC / S&P -24.75% / 13.47% |
WinABVC / S&P 397.78% / -1.41% |
| 2022-Q21/3 |
LoseABVC / S&P -61.17% / -16.10% |
LoseABVC / S&P -15.37% / 13.71% |
WinABVC / S&P 148.94% / 11.04% |
| 2022-Q10/3 |
LoseABVC / S&P -19.47% / -4.60% |
LoseABVC / S&P -82.27% / 15.97% |
LoseABVC / S&P 37.50% / 42.23% |
| 2021-Q41/3 |
WinABVC / S&P 46.75% / 11.03% |
LoseABVC / S&P -26.34% / 15.00% |
LoseABVC / S&P 4.08% / 96.40% |
| 2021-Q30/3 |
LoseABVC / S&P -54.26% / 0.58% |
LoseABVC / S&P -12.49% / 10.77% |
LoseABVC / S&P ABVC unavailable / 69.42% |
| 2021-Q21/3 |
WinABVC / S&P 12.22% / 8.55% |
LoseABVC / S&P -21.67% / 6.58% |
LoseABVC / S&P ABVC unavailable / 51.81% |
| 2021-Q11/3 |
LoseABVC / S&P -11.76% / 6.17% |
WinABVC / S&P 17.45% / -1.06% |
LoseABVC / S&P ABVC unavailable / 7.39% |
| 2020-Q41/3 |
WinABVC / S&P 27.50% / 12.15% |
LoseABVC / S&P -31.16% / -3.72% |
LoseABVC / S&P ABVC unavailable / -33.42% |
| 2020-Q31/3 |
WinABVC / S&P 33.33% / 8.93% |
LoseABVC / S&P -13.88% / -2.04% |
LoseABVC / S&P ABVC unavailable / -27.10% |
| 2020-Q22/3 |
WinABVC / S&P 22.45% / 20.54% |
WinABVC / S&P 47.88% / -0.46% |
LoseABVC / S&P ABVC unavailable / -27.11% |
| 2020-Q11/3 |
LoseABVC / S&P -43.94% / -19.60% |
WinABVC / S&P 159.25% / 3.47% |
LoseABVC / S&P ABVC unavailable / -14.75% |
| 2019-Q40/3 |
LoseABVC / S&P -51.44% / 9.07% |
LoseABVC / S&P ABVC unavailable / 5.36% |
LoseABVC / S&P ABVC unavailable / 2.99% |
| 2019-Q30/3 |
LoseABVC / S&P -30.77% / 1.70% |
LoseABVC / S&P ABVC unavailable / 5.02% |
LoseABVC / S&P ABVC unavailable / 0.21% |
| 2019-Q21/3 |
LoseABVC / S&P -51.85% / 4.30% |
LoseABVC / S&P ABVC unavailable / 6.64% |
WinABVC / S&P 133.33% / 8.65% |
| 2019-Q11/3 |
LoseABVC / S&P -25.00% / 13.65% |
LoseABVC / S&P ABVC unavailable / 8.12% |
WinABVC / S&P 328.57% / 14.29% |
| 2018-Q42/3 |
WinABVC / S&P 21.21% / -13.52% |
LoseABVC / S&P ABVC unavailable / 9.05% |
WinABVC / S&P 1400.00% / 18.23% |
| 2018-Q31/3 |
LoseABVC / S&P -13.16% / 7.71% |
LoseABVC / S&P ABVC unavailable / 10.21% |
WinABVC / S&P 400.00% / 19.06% |
| 2018-Q20/3 |
LoseABVC / S&P -5.00% / 3.43% |
LoseABVC / S&P ABVC unavailable / 9.03% |
LoseABVC / S&P ABVC unavailable / 14.46% |
| 2018-Q11/3 |
WinABVC / S&P 0.00% / -0.76% |
LoseABVC / S&P ABVC unavailable / 7.68% |
LoseABVC / S&P ABVC unavailable / 12.46% |
| 2017-Q40/3 |
LoseABVC / S&P 0.00% / 6.64% |
LoseABVC / S&P ABVC unavailable / 7.03% |
LoseABVC / S&P ABVC unavailable / 13.82% |
| 2017-Q30/3 |
LoseABVC / S&P 0.00% / 4.48% |
LoseABVC / S&P ABVC unavailable / 5.68% |
LoseABVC / S&P ABVC unavailable / 17.57% |
| 2017-Q20/3 |
LoseABVC / S&P 0.00% / 3.09% |
LoseABVC / S&P ABVC unavailable / 4.83% |
LoseABVC / S&P ABVC unavailable / 17.74% |
| 2017-Q10/3 |
LoseABVC / S&P 0.00% / 6.07% |
LoseABVC / S&P ABVC unavailable / 3.67% |
LoseABVC / S&P ABVC unavailable / 13.32% |
| 2016-Q40/3 |
LoseABVC / S&P 0.00% / 3.82% |
LoseABVC / S&P ABVC unavailable / 2.09% |
LoseABVC / S&P ABVC unavailable / 7.05% |
| 2016-Q30/3 |
LoseABVC / S&P 0.00% / 3.85% |
LoseABVC / S&P ABVC unavailable / 0.20% |
LoseABVC / S&P ABVC unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | ABVC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -71.87% | 20.78% |
| Annualized return | -71.87% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | ABVC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -97.78% | 83.14% |
| Annualized return | -53.32% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | ABVC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.78% | 319.30% |
| Annualized return | -45.74% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.